AIDS InfoNet Logo
This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

The Henry J. Kaiser Family Foundation
Site of the Week
November 2003

The Health Leader Award 2006
The Health Leader Award 2006

The HOPE Reward

Med411.com Medical Award

HealthAtoZ.com Featured Site Award

BuscaSalud.com

IBS Tales Hope Award

HealingWell.com Editor's Choice Award

Listed in Listed in Treasures of the Internet


AIDS InfoNet Logo.  The AIDS InfoNet - Reliable, Up-to-Date AIDS Treatment Information
International Association of Providers of AIDS Care
Revised November 5, 2013

Fact Sheet 427

Hydroxyurea (Hydrea)


WHAT IS HYDROXYUREA?
WHO SHOULD TAKE HYDROXYUREA?
WHAT ABOUT DRUG RESISTANCE?
HOW IS HYDROXYUREA TAKEN?
WHAT ARE THE SIDE EFFECTS?
HOW DOES HYDROXYUREA REACT WITH OTHER DRUGS?
THE BOTTOM LINE
 


WHAT IS HYDROXYUREA?

Hydroxyurea (Hydrea) is a drug that was tested as part of antiretroviral therapy (ART). It is manufactured by Bristol-Myers Squibb. Hydroxyurea is sometimes referred to as HU.

Hydroxyurea was approved for use against cancer. It also works against sickle cell anemia. Hydroxyurea has not been approved by the FDA for use against HIV.

Hydroxyurea blocks an enzyme produced by human cells. This enzyme makes building blocks used by cells that are multiplying. Cancer cells multiply very quickly, so when hydroxyurea blocks this enzyme, the cancer grows more slowly.

Hydroxyurea reduces the activation of the immune system. It is still being studied as part of HIV treatment.

These building blocks are also used by HIV when it multiplies. Some of the drugs used against HIV (the nucleoside analog reverse transcriptase inhibitors) are “fake” versions of these same building blocks. When HIV uses the fake materials, it can’t multiply.

 


WHO SHOULD TAKE HYDROXYUREA?

Hydroxyurea is not recommended as part of ART against HIV. Hydroxyurea has been studied in combination with the drugs ddI and d4T.  HU reduces gains in CD4 cells, increases ddI’s side effects, and can cause serious birth defects. It was studied due to its ability to intensify the effects of other medications. However, its side effects appear to outweigh its benefits for people with HIV.

There are no absolute rules about when to start ART. You and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking HIV medications. Fact Sheet 404 has more information about guidelines for the use of ART.

 


WHAT ABOUT DRUG RESISTANCE?

The HIV virus is sloppy when it makes copies of its genetic code (RNA). This means that many new copies of HIV are slightly different from the original (mutations). Some mutations can resist an ARV and continue to multiply. When this happens, the drug will stop working. This is called “developing resistance” to the drug.

Hydroxyurea blocks an enzyme produced by our own cells, not by HIV. This means that HIV cannot develop resistance to hydroxyurea. Taking hydroxyurea can slow down HIV mutations so that it takes much longer for resistance to develop to the other ARVs you are taking.

 


HOW IS HYDROXYUREA TAKEN?

Hydroxyurea is available in 500 mg tablets. The most common doses studied in HIV were 1 gram taken once a day, or 500 mg taken twice a day.

 


WHAT ARE THE SIDE EFFECTS?

The most serious side effects seen with hydroxyurea are pancreatitis and lactic acidosis that caused some deaths. Hydroxyurea may cause nausea, vomiting, and diarrhea. It can also lead to weight gain, hair loss, and changes in skin coloring. HU may cause birth defects, so pregnant women should not take hydroxyurea. It can also damage the bone marrow. This can result in anemia (a drop in the number of red blood cells) or neutropenia (a drop in the number of white blood cells).

Hydroxyurea appears to increase the risk of peripheral neuropathy. See Fact Sheet 555 for more information on neuropathy.

 


HOW DOES HYDROXYUREA REACT WITH OTHER DRUGS?

Hydroxyurea was sometimes prescribed with reverse transcriptase inhibitors such as ddI or d4T. Hydroxyurea intensifies the side effects of ddI.

Hydroxyurea’s side effects may be worse if taken with AZT, because both drugs can damage the bone marrow.

 


THE BOTTOM LINE

Hydroxyurea is used to reduce the activation of the immune system. It slows the growth of some cancers.

HU was studied as a way to intensify the HIV effects of ddI and d4T. This srategy was not successful.

 


 


Back to Fact Sheet Categories



New Mexico AIDS Education and Training Center The University of New Mexico Health Sciences Center International Association of Providers of AIDS Care

 

The AIDS InfoNet is a project of the New Mexico AIDS Education and Training Center at the University of New Mexico Health Sciences Center,
and the International Association of Providers of AIDS Care.
webmaster@aidsinfonet.org

 

United States National Library of Medicine

Partially funded by the National Library of Medicine



Search Our Site
Newest Fact Sheets
Print This Fact Sheet
You can print this fact sheet on a single page in Microsoft Word (.doc) format or Adobe Acrobat (.pdf) format. Click on the links below to open the document in your browser and then print it.
 Adobe Acrobat PDF
 Microsoft Word

You can print directly from your browser using the link below. The printout will probably go onto a second page.
 Print Version (Web)

Monthly E-mail Updates

The InfoNet updates its Fact Sheets frequently. A listing of each month's changes is posted to several e-mail lists.

If you would like to receive this monthly update by personal e-mail, please provide your e-mail address below, and click on the "Submit" button.



Subscribe
Unsubscribe